Historical record - last NADAC effective date: 2/22/2017

Product Information

LISINOPRIL 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0161 per EA under NDC 65862003899. Its NADAC has been published 170 times since Nov 28, 2013.

FDA first approved this application on Feb 22, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISINOPRIL 5 MG TABLET

Lisinopril
$0.0161per EA

Strength

5 mg/1

NDC

65862003899

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

2/22/2017

Active Ingredients

LISINOPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA077622

FDA Approved

2/22/2006

TE Code

AB

On Market Since

2/22/2006

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for LISINOPRIL 5 MG TABLET has been published 170 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0161 per EA
All-time high$0.0194 (Nov 16, 2016)
All-time low$0.0150 (Nov 18, 2015)
Median price$0.0166
Average price$0.0170
Largest weekly change+26.6% (Dec 23, 2015)
Weeks tracked170
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.6%

Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISINOPRIL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0161 per EA (NDC 65862003899), effective Feb 22, 2017.

How has the price of LISINOPRIL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for LISINOPRIL 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LISINOPRIL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for LISINOPRIL 5 MG TABLET has ranged from a low of $0.0150 (Nov 18, 2015) to a high of $0.0194 (Nov 16, 2016), with a median of $0.0166 per EA.

Are there cheaper alternatives to LISINOPRIL 5 MG TABLET?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LISINOPRIL 5 MG TABLET, is $0.0148 per EA — about 8% below LISINOPRIL 5 MG TABLET.

Who manufactures LISINOPRIL 5 MG TABLET?

LISINOPRIL 5 MG TABLET (NDC 65862003899) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.